The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(S)-1-(2-(Cyclopropylmethoxy)propyl)-3-(4-methyl-5-(pyridin-4-ylethynyl)thiazol-2-yl)urea ID: ALA4744017
PubChem CID: 59615748
Max Phase: Preclinical
Molecular Formula: C19H22N4O2S
Molecular Weight: 370.48
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: Cc1nc(NC(=O)NC[C@H](C)OCC2CC2)sc1C#Cc1ccncc1
Standard InChI: InChI=1S/C19H22N4O2S/c1-13(25-12-16-3-4-16)11-21-18(24)23-19-22-14(2)17(26-19)6-5-15-7-9-20-10-8-15/h7-10,13,16H,3-4,11-12H2,1-2H3,(H2,21,22,23,24)/t13-/m0/s1
Standard InChI Key: MUCBGWQDHLDMPA-ZDUSSCGKSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
7.8267 -19.1769 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
8.6526 -19.1769 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9084 -18.3918 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2417 -17.9029 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.5753 -18.3918 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6944 -18.1390 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7895 -18.1382 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.1750 -18.6883 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3461 -19.4961 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.1396 -19.8448 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6219 -20.5101 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1082 -21.1796 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3939 -18.4330 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.7824 -18.9818 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0013 -18.7265 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3898 -19.2752 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.6087 -19.0199 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9971 -19.5687 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1945 -19.7396 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7432 -20.3513 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7706 -21.9335 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2562 -22.6026 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0800 -22.5165 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.4160 -21.7556 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9283 -21.0897 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8319 -17.9224 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 2 0
5 1 1 0
3 6 1 0
5 7 1 0
7 8 1 0
8 9 2 0
10 11 3 0
2 10 1 0
11 12 1 0
8 13 1 0
13 14 1 0
15 14 1 0
15 16 1 0
16 17 1 0
17 18 1 0
19 18 1 0
20 19 1 0
18 20 1 0
12 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 12 1 0
15 26 1 1
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 370.48Molecular Weight (Monoisotopic): 370.1463AlogP: 3.18#Rotatable Bonds: 6Polar Surface Area: 76.14Molecular Species: NEUTRALHBA: 5HBD: 2#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 7.89CX Basic pKa: 4.47CX LogP: 2.76CX LogD: 2.65Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.77Np Likeness Score: -1.57
References 1. Bandarage UK,Aronov AM,Cao J,Come JH,Cottrell KM,Davies RJ,Giroux S,Jacobs M,Mahajan S,Messersmith D,Moody CS,Swett R,Xu J. (2021) Discovery of a Novel Series of Potent and Selective Alkynylthiazole-Derived PI3Kγ Inhibitors., 12 (1): [PMID:33488974 ] [10.1021/acsmedchemlett.0c00573 ]